Related Experiment Videos

Chronic granulomatous disease in pediatric patients: 25 years of experience

P Soler-Palacín1, C Margareto, P Llobet

  • 1Immunology Unit, Vall d'Hebron University Hospital, Barcelona, Spain.

Insights

Chronic granulomatous disease (CGD) is a rare immune deficiency causing severe bacterial and fungal infections. Early diagnosis via clinical suspicion and flow cytometry is crucial for management and preventing fatal outcomes.

Area of Science:

  • Immunology
  • Pediatrics
  • Genetics

Background:

  • Chronic granulomatous disease (CGD) is a primary immune deficiency affecting phagocyte function, leading to life-threatening bacterial and fungal infections.
  • It occurs in approximately 1 in 200,000 newborn infants, with defects in oxygen metabolite production by phagocytes.

Purpose of the Study:

  • To review the clinical records of pediatric patients diagnosed with CGD.
  • To analyze the clinical manifestations, diagnostic methods, infectious agents, and outcomes in a cohort of CGD patients.

Main Methods:

  • Retrospective review of clinical records of 13 pediatric patients diagnosed with CGD between 1980 and 2005.
  • Diagnosis was initially established using the nitroblue tetrazolium test and confirmed by flow cytometry and genetic techniques (gp91).

Main Results:

  • All 13 patients were male, with a mean age at diagnosis of 36 months.
  • Common manifestations included abscesses, pneumonia, osteomyelitis, and sepsis, caused by various bacteria (e.g., Staphylococcus aureus, Serratia, Klebsiella) and fungi (e.g., Aspergillus).
  • A total of 88 infections were recorded, with Aspergillus and Staphylococcus species being frequently isolated pathogens. Four deaths occurred due to severe infections and complications.

Conclusions:

  • Clinical suspicion supported by flow cytometry is key for diagnosing CGD and identifying carrier relatives.
  • Prophylactic measures and medical management are essential to prevent severe infections.
  • The effectiveness of Interferon-gamma (IFN-gamma) as a treatment remains controversial.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...